CorVista Health is applying machine learning to develop a novel cardiac diagnostic platform, CorVista® System, with the aim of transforming cardiovascular care and the patient experience. The CorVista System is a non-invasive, point-of-care solution that allows physicians to evaluate heart function without radiation, contrast agents, injections, fasting or exercise. For more information, visit www.corvista.com. The CorVista System is an investigational device limited by federal law to investigational use. The CorVista System is not available for commercial distribution.
CorVista® HealthChief Scientific Officer and Executive Vice President
The Janssen Pharmaceutical Companies of Johnson & JohnsonChief Technology Officer, Cardiovascular, Metabolism and Pulmonary Hypertension Therapeutic Areas
Johnson and Johnson, Janssen PharmaceuticalsChief Technology Officer, Pulmonary Hypertension Therapeutic Area